ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ANTX AN2 Therapeutics Inc

2.56
0.02 (0.79%)
04 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)
Total Revenue 0000000
Operating Income -7.68M-10.33M-11.77M-12.48M-16.04M-16.6M-18.18M
Pre Tax Income -7.66M-10.12M-11.34M-11.84M-15.32M-15.8M-16.71M
Net Income -9.48M-10.12M-11.34M-11.84M-15.32M-15.8M-16.71M
Preferred Dividends -1.82M000000
Basic Earnings Per Share (EPS) 0000000
EBIT -7.68M-10.35M-11.81M-12.47M-15.32M-15.8M-16.71M
EBITDA -7.68M-10.33M-11.77M-12.48M-16.04M-16.6M-18.18M
Year End 31 December 2023 202120222023
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -21.61M-42.26M-69.64M
Pre Tax Income -21.54M-40.96M-64.73M
Net Income -28.06M-42.78M-64.73M
Preferred Dividends -6.52M-1.82M0
Basic Earnings Per Share (EPS) -0.005-2.205-2.177
EBIT -21.61M-42.31M-64.73M
EBITDA -21.61M-42.26M-69.64M

Your Recent History

Delayed Upgrade Clock